GeneReach Biotechnology (Taiwan) Statistic Functions Beta
| 4171 Stock | TWD 26.75 0.50 1.83% |
| Symbol |
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on GeneReach Biotechnology correlated with the market. If Beta is less than 0 GeneReach Biotechnology generally moves in the opposite direction as compared to the market. If GeneReach Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GeneReach Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GeneReach Biotechnology is generally in the same direction as the market. If Beta > 1 GeneReach Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
GeneReach Biotechnology Technical Analysis Modules
Most technical analysis of GeneReach Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GeneReach from various momentum indicators to cycle indicators. When you analyze GeneReach charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About GeneReach Biotechnology Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GeneReach Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of GeneReach Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing GeneReach Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GeneReach Biotechnology's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of GeneReach Biotechnology's intrinsic value. In addition to deriving basic predictive indicators for GeneReach Biotechnology, we also check how macroeconomic factors affect GeneReach Biotechnology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GeneReach Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GeneReach Biotechnology's short interest history, or implied volatility extrapolated from GeneReach Biotechnology options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 40 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Macroaxis Index Invested few shares | |
 | Banking Invested over 40 shares | |
 | Cash Cows Invested few shares | |
 | Impulse Invested few shares | |
 | FinTech Invested few shares | |
 | Semiconductor Invested few shares | |
Additional Tools for GeneReach Stock Analysis
When running GeneReach Biotechnology's price analysis, check to measure GeneReach Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneReach Biotechnology is operating at the current time. Most of GeneReach Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneReach Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneReach Biotechnology's price. Additionally, you may evaluate how the addition of GeneReach Biotechnology to your portfolios can decrease your overall portfolio volatility.